Mourad G - Search Results

1

Triple drug immunosuppression (cyclosporine, azathioprine and low-dose prednisolone): a safe and effective regimen in first-cadaver kidney transplantation.

Mourad G, Legendre C, Argiles A, Bonardet A, Mion C. Mourad G, et al. Transplant Proc. 1987 Oct;19(5):3672-3. Transplant Proc. 1987. PMID: 3313886 No abstract available.

2

Peliosis hepatis and nodular regenerative hyperplasia of the liver in renal transplants. Is cytomegalovirus the cause of this severe disease?

Mourad G, Bories P, Berthelemy C, Barneon G, Michel H, Mion C. Mourad G, et al. Transplant Proc. 1987 Oct;19(5):3697-8. Transplant Proc. 1987. PMID: 2823426 No abstract available.

3

Assessment of two strategies of neoral administration, early versus delayed, on renal function and efficacy in de novo renal transplant patients receiving myfortic, steroids, and anti-IL2R antibodies: 12-month results of a randomized, multicentre, open, prospective controlled study.

Mourad G, Rostaing L, Legendre Ch; Myriade FR01 Study Group. Mourad G, et al. Transplant Proc. 2005 Mar;37(2):920-2. doi: 10.1016/j.transproceed.2004.12.263. Transplant Proc. 2005. PMID: 15848575 Clinical Trial.

4

Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients.

Cristol JP, Mourad G, Argiles A, Seignalet J, Iborra F, Ramounau-Pigot A, Chong G, Mion C. Cristol JP, et al. Among authors: mourad g. Transplant Proc. 1992 Dec;24(6):2470-1. Transplant Proc. 1992. PMID: 1465835 No abstract available.

5

Role of anti-idiotypic antibodies in sensitized patients awaiting renal transplantation.

Ramounau-Pigot A, Mourad G, Cristol JP, Argiles A, Seignalet J. Ramounau-Pigot A, et al. Among authors: mourad g. Transplant Proc. 1992 Dec;24(6):2496. Transplant Proc. 1992. PMID: 1465843 No abstract available.

6

Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.

Mourad G, Cristol JP, Chong G, Lorho R, Argiles A, Seignalet J, Mion C. Mourad G, et al. Transplant Proc. 1992 Dec;24(6):2512-3. Transplant Proc. 1992. PMID: 1465849 No abstract available.

7

Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids.

Mourad G, Rostaing L, Legendre C, Garrigue V, Thervet E, Durand D. Mourad G, et al. Transplantation. 2004 Aug 27;78(4):584-90. doi: 10.1097/01.tp.0000129812.68794.cc. Transplantation. 2004. PMID: 15446319 Clinical Trial.

8

Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism.

Szwarc I, Argilés A, Garrigue V, Delmas S, Chong G, Deleuze S, Mourad G. Szwarc I, et al. Among authors: mourad g. Transplantation. 2006 Sep 15;82(5):675-80. doi: 10.1097/01.tp.0000232452.80018.ad. Transplantation. 2006. PMID: 16969292

9

[Functional reversibility of chronic cyclosporine nephrotoxicity in patients after kidney transplantation].

Mourad G, Halimi JM, Ribstein J, Mimran A, Mion C. Mourad G, et al. Presse Med. 1991 Nov 27;20(40):2028-9. Presse Med. 1991. PMID: 1837118 French.

10

Two-dimensional gel electrophoresis of urinary proteins in kidney diseases.

Argiles A, Mourad G, Mion C, Atkins RC, Haiech J. Argiles A, et al. Among authors: mourad g. Contrib Nephrol. 1990;83:1-8. doi: 10.1159/000418766. Contrib Nephrol. 1990. PMID: 2100696 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

366 results

Search Page

Filters